Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic

特发性尿酸性肾结石的发病机制:肾脂毒性的作用

基本信息

  • 批准号:
    8457149
  • 负责人:
  • 金额:
    $ 32.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2014-09-14
  • 项目状态:
    已结题

项目摘要

Project Summary Uric Acid (UA) nephrolithiasis constitutes 8-10% of kidney stones in the United States. Our group has previously characterized several distinct features of idiopathic UA nephrolithiasis (IUAN): (1) The principal underlying abnormality is an unduly acidic urine which increases the risk of UA precipitation. (2) The low urine pH is due to the combined effect of increased net acid excretion (NAE) and reduced ammonium (NH4+) excretion. (3) Patients with type 2 diabetes and/or obesity are at increased risk for IUAN. Our preliminary data suggest that (1) renal fat accumulation (steatosis) occurs in humans, and is associated with low NH4+/NAE, (2) steatosis in an animal model is associated with aciduria and impaired NH4+ excretion, features of IUAN, (3) steatosis in a cell culture model results in lipotoxicity which manifests as reduced NH4+ secretion, and (4) low urinary pH is necessary but not sufficient for UA stone formation, suggesting the presence of unknown promoters or the absence of inhibitors of UA crystallization. We hypothesize that three defects are present in UA stone formers: (1) Steatosis of the kidney which impairs renal NH4+ excretion, resulting in an acidic urine at any given acid load. (2) Increased endogenous organic acid production and NAE. (3) In IUAN patients, the lack of a urinary inhibitor and/or the presence of a promoter may additionally account for UA crystallization. Aim 1 of this proposal will determine the functional consequences of renal steatosis by correlating kidney fat content with urinary acid-base parameters in human subjects and in animal models of generalized and kidney- specific lipotoxicity. Aim 2 will evaluate the outcome of reversing renal steatosis in humans, animals, and cell culture systems. Aim 3 will characterize the urinary physicochemical background accounting for the formation of UA stones in IUAN patients using classical physicochemical techniques. This proposal lays the foundation for the novel concept of renal lipotoxicity, identify its pathophysiologic role in uric acid stone formation, characterize the urinary physicochemical background accounting for the formation of uric acid stones, and open new avenues for improved diagnosis and treatment of uric acid nephrolithiasis.
项目摘要 尿酸(UA)肾结石占美国肾结石的8-10%。我们集团 特发性UA肾结石(IUAN)的几个明显特征:(1)主要的 潜在的异常是过度酸性的尿液,这增加了UA沉淀的风险。(2)低尿 pH值是由于净酸排泄量(NAE)增加和铵(NH 4+)减少的综合作用所致。 排泄(3)患有2型糖尿病和/或肥胖的患者患IUAN的风险增加。我们的初步数据 提示(1)肾脏脂肪蓄积(脂肪变性)发生在人体中,并与低NH 4 +/NAE相关, (2)动物模型中脂肪变性与酸尿和NH 4+排泄受损相关,这是IUAN的特征,(3) 细胞培养模型中的脂肪变性导致脂毒性,其表现为减少的NH 4+分泌,和(4)低 尿pH值是UA结石形成所必需的,但不足以形成UA结石,这表明存在未知的 促进剂或不存在UA结晶的抑制剂。我们假设存在三个缺陷, UA结石形成者:(1)肾脏脂肪变性,损害肾脏NH 4+排泄,导致酸性尿 在任何给定的酸负荷下。(2)增加内源性有机酸的产生和NAE。(3)在IUAN患者中, 尿抑制剂的缺乏和/或促进剂的存在可另外解释UA结晶。 本提案的目的1将通过将肾脏脂肪与肾脏脂肪变性的相关性来确定肾脏脂肪变性的功能后果。 内容与尿酸碱参数在人类受试者和动物模型的广义和肾- 特异性脂毒性。目的2将评估逆转人、动物和细胞中肾脏脂肪变性的结果。 文化体系。目的3将描述尿理化背景的形成, 使用经典的理化技术对IUAN患者的UA结石进行分析。这一建议奠定了基础, 对于肾脂毒性的新概念,确定其在尿酸结石形成中的病理生理作用, 表征导致尿酸结石形成的尿液理化背景,以及 为提高尿酸性肾结石的诊断和治疗开辟了新的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KHASHAYAR SAKHAEE其他文献

KHASHAYAR SAKHAEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KHASHAYAR SAKHAEE', 18)}}的其他基金

Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic
特发性尿酸性肾结石的发病机制:肾脂毒性的作用
  • 批准号:
    7812212
  • 财政年份:
    2009
  • 资助金额:
    $ 32.3万
  • 项目类别:
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic
特发性尿酸性肾结石的发病机制:肾脂毒性的作用
  • 批准号:
    8072745
  • 财政年份:
    2009
  • 资助金额:
    $ 32.3万
  • 项目类别:
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis and Renal Lipotoxicity
特发性尿酸性肾结石的发病机制与肾脂毒性
  • 批准号:
    8271447
  • 财政年份:
    2009
  • 资助金额:
    $ 32.3万
  • 项目类别:
Pathogenesis of Idiopathic Uric Acid Nephrolithiasis: The Role of Renal Lipotoxic
特发性尿酸性肾结石的发病机制:肾脂毒性的作用
  • 批准号:
    7653921
  • 财政年份:
    2009
  • 资助金额:
    $ 32.3万
  • 项目类别:
INTEGRATED ASSESSMENT OF CALCIUM METABOLISM
钙代谢的综合评估
  • 批准号:
    7606302
  • 财政年份:
    2007
  • 资助金额:
    $ 32.3万
  • 项目类别:
MEDICAL EVALUATION AND TREATMENT OF OSTEOPOROSIS
骨质疏松症的医学评估和治疗
  • 批准号:
    7606361
  • 财政年份:
    2007
  • 资助金额:
    $ 32.3万
  • 项目类别:
PATHOPHYSIOLOGY AND MOLECULAR GENETIC BASIS OF GOUTY DIATHESIS
痛风素质的病理生理学和分子遗传学基础
  • 批准号:
    7606307
  • 财政年份:
    2007
  • 资助金额:
    $ 32.3万
  • 项目类别:
ALTERNATIVE ASSESSMENT OF INTESTINAL CALCIUM ABSORPTION
肠道钙吸收的替代评估
  • 批准号:
    7606343
  • 财政年份:
    2007
  • 资助金额:
    $ 32.3万
  • 项目类别:
EFFECT OF POTASSIUM ALKALI ON BONE LOSS AND STONE RISK INDUCED BY ATKINS' DIET
碱钾对阿特金斯饮食引起的骨质流失和结石风险的影响
  • 批准号:
    7606335
  • 财政年份:
    2007
  • 资助金额:
    $ 32.3万
  • 项目类别:
POST-TRANSPLANT PHOSPHATURIA: DURATION AND PATHOGENESIS
移植后磷酸盐尿:持续时间和发病机制
  • 批准号:
    7606345
  • 财政年份:
    2007
  • 资助金额:
    $ 32.3万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 32.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了